Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 144.53

-1.6%

2:40 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (739)	5/28/2001 9:13:49 PM
From: Spekulatius	Read Replies (1) of 1834

>> And, do you see any clouds? << Miljenko, at a current market cap of 930M$, NBIX is not cheap any more. I personally don't see a problem with NBIX drugs but unforeseen things happen. NBIX insomnia drugs looks very safe after extended Phase II tests but the toxicology threshold for insomnia drugs are very low, so a problem could still show up in Phase III. I just generally think that the risk/reward ratio for NBIX is not that good any more. I personally switched some funds into NRGN which is sort of a similar company but with a stock that has not appreciated much.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next